Novo Nordisk/ US6701002056 /
| 2024-06-07 10:10:00 PM | Chg. +0.48 | Volume | Bid12:43:51 PM | Ask12:43:51 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 142.88USD | +0.34% | 3.51 mill. Turnover: 350.71 mill. |
141.68Bid Size: 700 | 141.76Ask Size: 300 | 355.16 bill.USD | - | - |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 12.26 DKK | 17.89% |
| EPS Diluted: | - DKK | - |
| Revenues per Share: | - DKK | - |
| Book Value per Share: | - DKK | - |
| Cash Flow per Share: | - DKK | - |
| Dividend per Share: | - DKK | - |
| Total | in mill. | |
| Revenues: | 176,954.00 DKK | 25.68% |
| Net Income: | 55,525.00 DKK | 16.27% |
| Operating Cash Flow: | 78,887.00 DKK | - |
| Cash and Cash Equivalents: | 12,653.00 DKK | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | - | - |
| P/BV ratio: | - | - |
| P/CF Ratio: | - | - |
| PEG: | - | - |
| Earnings Yield: | - | - |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 355.16 bill. USD | 235.37 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | - | |
Profitability
| Gross Profit Margin: | 83.92% |
| EBIT Margin: | 42.28% |
| Net Profit Margin: | 31.38% |
| Return on Equity: | 66.51% |
| Return on Assets: | 23.01% |
Financial Strength
| Liquidity I / Cash Ratio: | 10.46% |
| Liquidity II / Quick Ratio: | 52.27% |
| Liquidity III / Current Ratio: | 89.46% |
| Debt / Equity Ratio: | 188.98% |
| Dynam. Debt / Equity Ratio: | 200.00% |
Efficiency
| Employees: | 55,185 |
| Personal Expenses / Employee: | - DKK |
| Revenues / Employee: | 3,206,559.75 DKK |
| Net Income / Employee: | 1,006,161.09 DKK |
| Total Assets / Employee: | 4,371,785.81 DKK |
| * Fiscal Year End: | 2022-12-31 |
| Accounting Standard: | IFRS |
| Currency: | DKK |
